Tiziana Life Sciences (TILS) Hits New 12-Month Low at $95.59

Shares of Tiziana Life Sciences PLC (LON:TILS) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 95.59 ($1.32) and last traded at GBX 99.85 ($1.38), with a volume of 7175 shares changing hands. The stock had previously closed at GBX 100 ($1.38).

Separately, Beaufort Securities reissued a “speculative buy” rating and issued a GBX 400 ($5.53) price objective on shares of Tiziana Life Sciences in a research report on Tuesday, December 19th.

The firm has a market capitalization of $121.93 and a PE ratio of -1,109.56.

ILLEGAL ACTIVITY WARNING: “Tiziana Life Sciences (TILS) Hits New 12-Month Low at $95.59” was originally reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.com-unik.info/2018/02/21/tiziana-life-sciences-tils-hits-new-12-month-low-at-95-59.html.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences PLC is a clinical-stage biotechnology company. The Company is focused on targeted drugs to treat diseases in oncology and immunology, with a focus on metastatic cancers. Its products in clinical stage include Milciclib and Foralumab. Its products in pre-clinical stage include TZLS-101 and TZLS-214.

Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit